Chronic Myelomonocytic Leukemia
The information in this section about chronic myelomonocytic leukemia (CMML) can help you talk with members of your healthcare team and take an active role in your treatment. Knowing what to expect and being able to make informed decisions about your cancer treatment are important aspects of coping with your disease. You can skim sections to find what you want to read now - and continue reading whenever you're ready for more information.
What You Should Know
- CMML is an uncommon blood cancer.
- Most people diagnosed with CMML are between ages 65 and 75 years.
- Many individual factors influence treatment outcomes.
- Hematologists and oncologists are specialists who treat people who have CMML or other types of blood cancer.
What You Should Do
- Talk with your doctor about your diagnostic tests and what the results mean.
- Seek treatment in a cancer center where doctors are experienced in treating patients with leukemia.
- Ask your doctor whether a clinical trial is a good treatment option for you.
What Is CMML?
Chronic myelomonocytic leukemia (CMML) is an uncommon blood cancer that has features of two other types of blood cancers. For this reason, the World Health Organization (WHO) classifies CMML as a mixed myelodysplastic/myeloproliferative disease.